We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Solving The Big Green Riddle...

For large scale adoption of cannabis in medical formulations, the quality, consistency, and trust in the raw ingredients are essential. To date, no one has been able to solve this all-important riddle...Until now.

Read More

Cannabics Bolsters Team to Develop Cannabinoid Treatments for Cancer

New team members will support Cannabics' data-discovery process with the goal of identifying new cannabinoid diagnostic tests and treatments for cancer.

Read More

North Dakota Selects Lab for Testing Medical Marijuana

State Medical Marijuana Director Jason Wahl says the lab will ensure medical cannabis dispensed in North Dakota is safe.

Read More

EVIO Labs Expands to L.A. to Meet Cannabis Analysis Demand

Due to California's July 1st testing deadline mandating licensed retailers to sell only lab tested product, the industry is expecting a significant uptick in the need for testing services.

Read More

Cannabis: It Matters How Young You Start

Canadian researchers find that boys who start smoking pot before 15 are much more likely to have a drug problem at 28 than those who start at 15 or after.

Read More

Testing the Moisture Content of Cannabis

A cannabis testing committee has now approved to standard testing methods to help analysts accurately measure the water content of cannabis.

Read More

Trends in Medical Cannabis: Epidiolex and the FDA

What does the recent FDA approval recommendation for Epidiolex mean for cannabis medicine? And, what's best, synthetic or natural cannabinoids? You can get answers in this Interview.

Read More

Faster Test for Cannabis Quality, Potency Developed

Traditional tests can take upwards of 20 minutes to perform, this new one can be done in under seven.

Read More

CBD Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.

Read More